Uncategorized

The Maryland Department of Commerce focuses on attracting, retaining, and expanding businesses and creating jobs in Maryland. The department will also place a renewed focus on better serving the diverse industries and geographic regions of the state, and marketing Maryland’s many assets to companies across the nation and abroad.

Roche was one of the first companies to bring targeted treatments to patients. With our combined strength in pharmaceuticals and diagnostics, we are better equipped than any other company to further drive personalised healthcare. Two-thirds of our Research and Development projects are being developed with companion diagnostics.

Our scientific heritage is grounded in pushing the boundaries of small molecule discovery and development. For decades, our scientists have led the way in identifying the right chemical leads. Our early discovery and high throughput screening capabilities enable us to screen thousands of compounds a day to identify molecules with potential to inhibit or activate the target.

Alexandria Real Estate Equities, Inc. (NYSE: ARE), an S&P 500^® company, is a best-in-class, mission-driven life science REIT making a positive and lasting impact on the world. As the pioneer of the life science real estate niche since its founding in 1994, Alexandria is the preeminent and longest-tenured owner, operator, and developer of collaborative life science, agtech, and technology campuses in AAA innovation cluster locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle. In Maryland, Alexandria has established a significant presence of approximately 4 million square feet of high-quality office/laboratory space primarily located in Rockville and Gaithersburg. As one of Maryland’s most active early-stage investors, Alexandria also actively invests in disruptive life science companies as well as promising agrifoodtech, climate innovation, and technology companies through its strategic venture capital platform, Alexandria Venture Investments.  

Noble Life Sciences is a preclinical contract research organization (CRO)  owned and operated by scientists with decades of experience in drug, vaccine, and medical device development. In addition to offering GLP and non-GLP services including in-vivo and in-vitro specialized models, Noble’s team of scientists implement effective and efficient approaches to help guide your research and development programs.

The WIB-Washington DC/Baltimore Chapter community is dedicated to creating opportunities and careers for women in the life science industry and to encouraging women in our region to translate novel discoveries into products. Our chapter symbolizes the significance of promoting the dynamic women in the biotechnology and life sciences industry in this area and globally. Our membership consists of professionals at leading pharmaceutical, biotechnology, device and diagnostics companies, non-profits, academic institutions, and support service companies, including law firms, consultants, and financial service firms.